Operating Lease, Liability, Current of ELITE PHARMACEUTICALS INC /NV/ from 02 Apr 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Operating Lease, Liability, Current in USD history and change rate from 02 Apr 2019 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Operating Lease, Liability, Current for the quarter ending 31 Dec 2025 was $519,739, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $519,739 +$62,342 +14% 31 Dec 2025 10-Q 17 Feb 2026 2026 Q3
Q3 2025 $503,513 +$81,190 +19% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 $487,759 +$70,995 +17% 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 $472,390 +$60,972 +15% 31 Mar 2025 10-Q 17 Feb 2026 2026 Q3
Q4 2024 $457,397 +$431,166 +1644% 31 Dec 2024 10-Q 13 Feb 2025 2025 Q3
Q3 2024 $422,323 +$420,160 +19425% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q2
Q2 2024 $416,764 +$408,178 +4754% 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q1 2024 $411,418 +$396,504 +2659% 31 Mar 2024 10-K 30 Jun 2025 2025 FY
Q4 2023 $26,231 +$5,082 +24% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 $2,163 -$22,902 -91% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q2
Q2 2023 $8,586 -$198,787 -96% 30 Jun 2023 10-Q 14 Aug 2023 2024 Q1
Q1 2023 $14,914 -$188,039 -93% 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 $21,149 -$132,664 -86% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 $25,065 -$184,629 -88% 30 Sep 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 $207,373 +$1,553 +0.76% 30 Jun 2022 10-Q 15 Aug 2022 2023 Q1
Q1 2022 $202,953 +$14,863 +7.9% 31 Mar 2022 10-K 29 Jun 2023 2023 FY
Q4 2021 $153,813 -$67,353 -30% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 $209,694 -$7,080 -3.3% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 $205,820 -$6,627 -3.1% 30 Jun 2021 10-Q 16 Aug 2021 2022 Q1
Q1 2021 $188,090 -$20,094 -9.7% 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 $221,166 +$17,182 +8.4% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 $216,774 +$16,907 +8.5% 30 Sep 2020 10-Q 16 Nov 2020 2021 Q2
Q2 2020 $212,447 +$16,635 +8.5% 30 Jun 2020 10-Q 14 Aug 2020 2021 Q1
Q1 2020 $208,184 -$167,109 -45% 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q4 2019 $203,984 31 Dec 2019 10-Q 10 Feb 2020 2020 Q3
Q3 2019 $199,867 30 Sep 2019 10-Q 12 Nov 2019 2020 Q2
Q2 2019 $195,812 30 Jun 2019 10-Q 09 Aug 2019 2020 Q1
Q1 2019 $375,293 02 Apr 2019 10-Q 09 Aug 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.